Advances in Stem Cell Therapies for Ocular Diseases: Progress in Clinical Trials and Future Perspectives
- 20 August 2025
- journal article
- review article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (8) , 2386-2406
Abstract
Stem cell-based therapies hold promise for vision-threatening ocular diseases by promoting tissue repair and restoring visual function. Stem cells are classified by differentiation potential into two main types. Pluripotent stem cells, such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), possess the capacity to differentiate into somatic cells. Multipotent adult stem cells, such as mesenchymal stem cells (MSCs), are restricted to differentiating into cell types within specific lineages. The therapeutic potential of stem cells is discussed in the context of treating corneal diseases, glaucoma, and retinal disorders such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD). This review focuses on the clinical trials of stem cell therapies for ocular diseases and discusses prospects in the field. Despite the considerable promise of these preclinical results in restoring visual function, significant challenges in clinical application remain, such as insufficient long-term cell survival, incomplete functional integration into host tissues, and the potential risk of oncogenic transformation. Future progress will depend on the development of standardized protocols, efficient delivery methods, and interdisciplinary collaboration to effectively translate preclinical advances into clinical applications. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (82201210, 82222030)
- Sichuan Science and Technology Program (2023NSFSC1660)
- Postdoctor Research Fund of West China Hospital, Sichuan University (2024HXBH082)
- National Key Research and Development Program of China (2023YFC3403300)
- 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University (ZYYC23009)
This publication has 152 references indexed in Scilit:
- Bone Marrow Mesenchymal Stem Cells: Biological Properties and Their Role in Hematopoiesis and Hematopoietic Stem Cell TransplantationStem Cell Reviews and Reports, 2011
- Growth Factors, Matrices, and Forces Combine and Control Stem CellsScience, 2009
- Broader Implications of Defining Standards for the Pluripotency of iPSCsCell Stem Cell, 2009
- Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applicationsJournal of Molecular Medicine, 2008
- Reprogramming somatic cells towards pluripotency by defined factorsCurrent Opinion in Biotechnology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Neural progenitor cells from postmortem adult human retinaBritish Journal of Ophthalmology, 2005
- The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-reviewOphthalmic Genetics, 2003
- Induction of photoreceptor-specific phenotypes in adult mammalian iris tissueNature Neuroscience, 2001
- Reconstruction of Damaged Corneas by Transplantation of Autologous Limbal Epithelial CellsNew England Journal of Medicine, 2000